Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2023-08-03 Director's Dealing
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
Director's Dealing 2023
Director's Dealing
2023-08-03 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-03 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 27, 2023, by Boston Scientific Corporation. It specifically mentions in Item 2.02 that the company issued a press release announcing financial results for the second quarter ended June 30, 2023, and that the press release is furnished as Exhibit 99.1. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 3819 characters, which is relatively short and consistent with a regulatory announcement rather than a full financial report. According to the rules, such a document that announces or furnishes a press release of financial results without containing the full financial data should be classified as a Regulatory Filing (RNS), as it is a current report filing and not the earnings release itself or an interim report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-07-27 English
Director's Dealing 2023
Director's Dealing
2023-07-18 English
Regulatory Filings 2023
Regulatory Filings
2023-07-17 English
Director's Dealing 2023
Director's Dealing
2023-07-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.